You are logged on as Guest.
RegisterLoginShopping cart (Empty)
 United States

RIG-I (human), pAb (AT111)

 
ALX-210-932-C100 100 µg 280.00 USD
 

Product Specification

Alternative Name:Probable ATP-dependent RNA helicase DDX58, Retinoic acid-inducible gene 1 protein, DEAD-box protein 58, RIG-1
 
Concentration:1mg/ml
 
Purity Detail:Protein A-affinity purified.
 
Formulation:Liquid. In PBS containing 0.02% sodium azide.
 
Immunogen:Recombinant human RIG-I (retinoic acid-inducible gene 1 protein) (aa 201-713).
 
Source/Host:From rabbit.
 
Specificity:Recognizes human RIG-I.
 
Application:Immunoprecipitation (1:100)
Western blot (1:1'000)
 
Short Term Storage:+4°C
 
Long Term Storage:-20°C
 
Use/Stability:Stable for at least 1 year after receipt when stored at -20°C.
 
Handling:After opening, prepare aliquots and store at -20°C.
Avoid freeze/thaw cycles.
 
Miscellaneous/General:RIG-I (retinoic acid-inducible gene I; Ddx58), a member of the DEAD-box RNA helicases, is activated by cytoplasmic dsRNA and 5’-ppp RNA produced during the viral replication. The protein is characterized by a N-terminal region with two caspase recruitment domains (CARD) and a C-terminal region harboring potential ATP-dependent RNA helicase activity. RIG-1 recruits the CARD adaptor inducing IFN-β (Cardif) in a CARD-CARD-dependent manner resulting in NF-κB and IRF3 activation.
 

Product Literature References

Activation of an immunoregulatory and antiviral gene expression program in poly(I:C)-transfected human neutrophils: N. Tamassia, et al.; J. Immunol. 181, 6563 (2008), Abstract;

General Literature References

5’-Triphosphate RNA is the ligand for RIG-I: V. Hornung, et al.; Science 314, 994 (2006), Abstract;
RIG-I-mediated antiviral responses to single-stranded RNA bearing 5’-phosphates: A. Pichlmair, et al.; Science 314, 997 (2006), Abstract;
Virology. Sensing viral RNA amid your own: T. Fujita; Science 314, 935 (2006), Abstract;

Related Literature

Product Flyers
Antiviral Signaling
Add to order list
Antiviral Signaling 17-May-09
Download as PDF

All new literature pieces

©2010 Enzo Life Sciences, Inc.,